HE Shu-ying

466 total citations
18 papers, 407 citations indexed

About

HE Shu-ying is a scholar working on Molecular Biology, Oncology and Complementary and alternative medicine. According to data from OpenAlex, HE Shu-ying has authored 18 papers receiving a total of 407 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 7 papers in Oncology and 6 papers in Complementary and alternative medicine. Recurrent topics in HE Shu-ying's work include Saffron Plant Research Studies (7 papers), Angiogenesis and VEGF in Cancer (5 papers) and Phytochemical and Pharmacological Studies (4 papers). HE Shu-ying is often cited by papers focused on Saffron Plant Research Studies (7 papers), Angiogenesis and VEGF in Cancer (5 papers) and Phytochemical and Pharmacological Studies (4 papers). HE Shu-ying collaborates with scholars based in China. HE Shu-ying's co-authors include Zhiyu Qian, Futian Tang, Guanglin Xu, Na Wen, Liang Sheng, Chenghua Zhou, Min Xiang, Zhunan Gong, Lei Gao and Weiping Yu and has published in prestigious journals such as Carbohydrate Polymers, Molecules and Life Sciences.

In The Last Decade

HE Shu-ying

18 papers receiving 390 citations

Peers

HE Shu-ying
Lina Yang China
Yanna Jiao China
Rongling Zhong China
Hsiao‐Ting Wu Taiwan
Ji‐Yao Chou Hong Kong
Kyriaki Hatziagapiou Greece
Tae‐Hyeon Kim South Korea
Ying‐Ling Chang Taiwan
Syed Imran Bukhari Pakistan
Lianmei Wang China
Lina Yang China
HE Shu-ying
Citations per year, relative to HE Shu-ying HE Shu-ying (= 1×) peers Lina Yang

Countries citing papers authored by HE Shu-ying

Since Specialization
Citations

This map shows the geographic impact of HE Shu-ying's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by HE Shu-ying with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites HE Shu-ying more than expected).

Fields of papers citing papers by HE Shu-ying

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by HE Shu-ying. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by HE Shu-ying. The network helps show where HE Shu-ying may publish in the future.

Co-authorship network of co-authors of HE Shu-ying

This figure shows the co-authorship network connecting the top 25 collaborators of HE Shu-ying. A scholar is included among the top collaborators of HE Shu-ying based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with HE Shu-ying. HE Shu-ying is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
He, Weijie, Wenxing Xu, Xu Dong Zhang, et al.. (2024). Midpoint transverse process to pleura block for postoperative analgesia following laparoscopic renal cyst decortication: Two case reports. World Journal of Clinical Cases. 12(18). 3629–3635. 1 indexed citations
2.
Wu, Gang, et al.. (2021). A novel histone deacetylase inhibitor LT-548-133-1 induces apoptosis by inhibiting HDAC and interfering with microtubule assembly in MCF-7 cells. Investigational New Drugs. 39(5). 1222–1231. 10 indexed citations
3.
Wan, Xinyu, et al.. (2018). Low-Molecular-Weight Heparins: Reduced Size Particulate Systems for Improved Therapeutic Outcomes. Molecules. 23(7). 1757–1757. 11 indexed citations
4.
Wu, Jie, Xinchao Yu, Xuan Qian, et al.. (2017). Heparin-derived oligosaccharide inhibits vascular intimal hyperplasia in balloon-injured carotid artery. Chinese Journal of Natural Medicines. 15(6). 442–450. 5 indexed citations
5.
Wang, Hui‐Fang, et al.. (2017). Modulation of binding to vascular endothelial growth factor and receptor by heparin derived oligosaccharide. Carbohydrate Polymers. 174. 558–564. 7 indexed citations
6.
7.
Yu, Danfeng, et al.. (2014). Effect of Heparin-Derived Oligosaccharide on bFGFR1 and bFGFR2 in Vascular Smooth Muscle Cells. Vascular and Endovascular Surgery. 48(4). 289–296. 4 indexed citations
8.
Li, Li, et al.. (2012). Effect of Heparin-Derived Oligosaccharide on Vascular Smooth Muscle Cell Proliferation and the Signal Transduction Mechanisms Involved. Cardiovascular Drugs and Therapy. 26(6). 479–488. 6 indexed citations
9.
Li, Li, Ting Gao, HE Shu-ying, Guanglin Xu, & Lina Yang. (2012). Effect of heparin-derived oligosaccharide on vascular smooth muscle cell proliferation through inhibition of PKC-alpha expression.. PubMed. 47(8). 993–1000. 2 indexed citations
10.
Li, Wei, et al.. (2012). Effect of Heparin-Derived Oligosaccharide on Vascular Smooth Muscle Cell Proliferation. Vascular and Endovascular Surgery. 46(5). 393–400. 2 indexed citations
11.
Zhou, Chenghua, Min Xiang, HE Shu-ying, & Zhiyu Qian. (2010). Protein kinase C pathway is involved in the inhibition by crocetin of vascular smooth muscle cells proliferation. Phytotherapy Research. 24(11). 1680–1686. 16 indexed citations
12.
Chen, Liping, et al.. (2010). Effects and Mechanisms of Lycopene on the Proliferation of Vascular Smooth Muscle Cells. Chinese Journal of Natural Medicines. 8(3). 218–222. 4 indexed citations
13.
Zhou, Chenghua, Min Xiang, HE Shu-ying, & Zhiyu Qian. (2009). Crocetin inhibits cell cycle G1/S transition through suppressing cyclin D1 and elevating p27kip1 in vascular smooth muscle cells. Phytotherapy Research. 24(7). 975–981. 13 indexed citations
14.
Xu, Guanglin, Zhunan Gong, Weiping Yu, et al.. (2006). Increased Expression Ratio of Bcl‐2/Bax Is Associated with Crocin‐Mediated Apoptosis in Bovine Aortic Endothelial Cells. Basic & Clinical Pharmacology & Toxicology. 100(1). 31–35. 44 indexed citations
15.
Shu-ying, HE, Zhiyu Qian, Na Wen, et al.. (2006). Influence of Crocetin on experimental atherosclerosis in hyperlipidamic-diet quails. European Journal of Pharmacology. 554(2-3). 191–195. 65 indexed citations
16.
Zhou, Chenghua, Zhiyu Qian, Min Xiang, & HE Shu-ying. (2006). Involvement of Ca2+ in the inhibition by crocetin of angiotensin II-induced ERK1/2 activation in vascular smooth muscle cells. European Journal of Pharmacology. 554(2-3). 85–91. 13 indexed citations
17.
Shu-ying, HE, Zhiyu Qian, Futian Tang, et al.. (2005). Effect of crocin on experimental atherosclerosis in quails and its mechanisms. Life Sciences. 77(8). 907–921. 176 indexed citations
18.
Shu-ying, HE, et al.. (2004). Effect of crocin on intracellular calcium concentration in cultured bovine aortic smooth muscle cells.. PubMed. 39(10). 778–81. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lina Yang Breakdown of academic impact, for papers by Yanna Jiao Breakdown of academic impact, for papers by Rongling Zhong Breakdown of academic impact, for papers by Hsiao‐Ting Wu Breakdown of academic impact, for papers by Ji‐Yao Chou Breakdown of academic impact, for papers by Kyriaki Hatziagapiou Breakdown of academic impact, for papers by Tae‐Hyeon Kim Breakdown of academic impact, for papers by Ying‐Ling Chang Breakdown of academic impact, for papers by Syed Imran Bukhari Breakdown of academic impact, for papers by Lianmei Wang
Rankless by CCL
2026